LWL
FTH

Leo Wealth LLC’s Faeth Therapeutics FTH Stock Holding History

Leo Wealth LLC’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-742
Closed -$9.21K – 361
2024
Q2 		$9.21K Hold
742
– – ﹤0.01% 331
2024
Q1 		$15.6K Hold
742
– – ﹤0.01% 332
2023
Q4 		$10.3K Buy
+742
New +$10.1K ﹤0.01% 325

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Leo Wealth LLC's FTH Position: Q3 2024 in Review

Leo Wealth LLC sold out of Faeth Therapeutics (FTH) in Q3 2024, closing a stake of 742 shares — an estimated $9.21K sold.

Leo Wealth LLC first reported a position in FTH in Q4 2023 and held it in 3 quarters. The position peaked at $15.6K in Q1 2024. 19 funds tracked by Wall St. Rank hold FTH as of Q3 2024.

  • Leo Wealth LLC reported no remaining Faeth Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Leo Wealth LLC sold 742 Faeth Therapeutics shares in Q3 2024, an estimated $9.21K.
  • Leo Wealth LLC first reported a position in Faeth Therapeutics in Q4 2023 and held it in 3 quarters.
  • Leo Wealth LLC's Faeth Therapeutics position peaked at $15.6K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2024.

Based on Leo Wealth LLC's 13F filing for Q3 2024, filed 21 Oct 2024.